News
Our First Newsletter is Here !
We are thrilled to bring you the latest edition of our monthly newsletter. This month, we have curated a selection of engaging articles, important updates, and upcoming events that you won’t want to miss. In This Issue: Introduction to mucus rheology Context and...
Rheonova attend the ATS 2024
We are happy to share that Rheonova participated in the ATS (American Thoracic Society) conference held at the San Diego International Convention Center from May 19 to 22, 2024. During this internationnal congress we showcased a poster discussing a preliminary study...
Rheonova was present at the European Cystic Fibrosis Society – Basic science 2023
We are thrilled to announce that our colleague Lydia Esteban Enjuto participated in the ECFS Basic Science from 20-23 March 2024 in Malta. She presented her poster titled : P70 « Impact of Triple Therapy on Mucus Rheology and Bacteriology in Cystic Fibrosis » Duing...
North American Cystic Fibrosis Conference 2023
Rheonova was present at the NACFC 2023 held in Phoenix, Arizona from Nov 2nd to Nov 4th. Our colleague Lama Soueidan was happy to present our latest work on sputum rheology titled: "Sputum from CF and non-CF obstructive diseases: similarities and differences". Contact...
Rheonova is exhibiting at the European Respiratory Society International Congress in Milan from september 9th to 13th.
I am happy to inform you that Rheonova will be at the ERS international congress 2023 held in Milan from September 9th to 13th, Visit our Booth J04: Rheomuco by Rheonova and meet with our colleagues Lama Soueidan and Jérémy patarin in order to discuss our latest...
Rheonova will be present at the ATS 2023
Rheonova will be exhibiting at the American Thoracic Society Conference 2023 held at Walter E. Washington Convention Center in Washington DC From May 19th to May 24th. Stop by our booth N°2620 to check Rheomuco and discuss with our experts about mucus rheology and how...
Rheonova was present at the ECFS basic science conference 2023
Rheonova participated in the ECFS basic science conference 2023 held in Dubrovnik (Croatia) from March 29th to April 1rst 2023. Our colleague Lydia Esteban Enjuto presented a part of her thesis work titled " sputum viscoelasticity is driven by concentration in organic...
Rheonova Participated in the North American Cyctic Fibrosis Conference 2022
Rheonova was present at the NACFC 2022 held at the convention center in Philadelphia, from November 2nd untill november 5th. After 2 years online, it was the opportunity for the cystic fibrosis community to get back together to discuss the latest development in this...
Rheonova was present at the Lung Invitro Event 2022 organised by Epithelix
Rheonova participated in the Lung Invitro Event 2022 at the Hyatt Regency, Nice. LIVe2022 intends to be a unique exchange platform for scientists interested in in vitro respiratory researches, stakeholders from academia, pharma, biotech,...
Rheonova participated at ECFS basic Science 2022
Rheonova was present at the ECFS basic science 2022 at Albufeira. Our PhD student Lydia ESTEBAN ENJUTO presented her work on cystic fibrosis sputum handling for rheology. Muco-obstructive diseases, including cystic fibrosis, COPD or severe asthma feature an alteration...
Rheomuco CE marking funding
Rheonova is supported by the Auvergne Rhône-Alpes region to ensure compliance with the new European regulation for CE marking of our medical device Rheomuco and the associated quality management system. The region, in collaboration with the Agency, Lyonbiopole and...
RheoCare project has received funding from the EU’s H2020 programme
Rheonova is proud to announce that the RheoCare project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 889360. The aim is to implement an automated sample manipulation device on the Rheomuco....
BronchoClogDrain : A new innovative research project
Rheonova is pleased to inform you that the research project BronchoClogDrain has received funding from the French National Research Agency (ANR). This project brings together various academic and private stakeholders focusing on obstructive lung diseases, specifically...
Rheonova participated to CPLF 2022
Rheonova was present at the Congrès de Pneumologie de Langue Française 2022 in Lille where we presented our latest work on bronchial mucus heterogeinity: micro- and macro-rheology study Abstract In lung muco-obstructive diseases, such as cystic fibrosis, chronic...
Happy New Year 2022!
Rheonova wishes you happy new year 2022!this past year have been rich, challenging and exciting, here is a small preview!
Rheonova granted the first regional PSPC
We are happy to announce that Rheonova, in collaboration with Cedrat Technologies and the laboratories TIMA and LRP, have been granted the regional PSPC for the project MucoPiezoRheo. This project aims to develop a medical device for personalized diagnosis and...
Meet us at the NACFS in Nashville from October 31 to November 2, 2019
North American Cystic Fibrosis Conference will stand in few days. Rheonova team would be glad to meet you there and present its Poster n°529 “RHEOLOGICAL SIGNATURE OF INDUCTION ON CF SPUTUM: SPONTANEOUS VERSUS HYPERTONIC SALINE VERSUS RHDNASE”
Pioneer in the chronic respiratory diseases sector, Rheonova opens its capital
Following Rheomuco's first sales to research laboratories in Europe, Rheonova wishes to boost its commercial activity. And to bring Rheomuco to the patient's bedside, 2 new clinical trials are underway. The first at Cochin Hospital for patients with cystic fibrosis...
13 European companies selected under EIT Health Go Global program to reach canadian market and healthtech innovation hubs
Following an intensive selection process through a dedicated European-Canadian jury, thirteen European companies are laureates of the 2019 edition of the GoGlobal Canada program and will benefit from a unique gateway to Canada. Click here for the full press release
Rheonova among the “Concours Innovation” winners
Winner of the "Concours Innovation", Rheonova will continue the clinical validation for a diagnostic test for Cystic Fibrosis. A financial aid of 352.000 € for the MucoCF project using the medical device Rheomuco® For the press release, click here
Rheonova and the Laboratory for Rheology & Process create «MUCUS».
Rheonova and the French Laboratory for Rheology & Process are proud to present the LabCom «MUCUS», a joint laboratory focused on new diagnostic and monitoring strategies for chronic pulmonary diseases. A 300K€ funding to sustain research partnership between...
Do not miss Rheonova at the ERS international congress held in Paris, France, 15-19 September.
Jeremy Patarin is looking forward to discussing the importance of mucus rheology during his poster presentation on the 18th of September starting 14h45 in room 7.2D. The 28th ERS international congress is the biggest meeting in respiratory medicine which makes it the...
Rheonova will be at the 41st ECFC in Belgrade, 06-08 June 2018
Rheonova looks forward to seeing you at the 41st Conference which will take place in Belgrade, Serbia, 6-9 June 2018. The conference will gather leading CF caregivers and researchers. The three-day program includes seminars, round table talks, Meet the Expert sessions...
Rheonova will be present at the MT-CONNECT, Nuremberg, 11-12 March 2018
On March 11-12, 2018, Rheonova will be present at the MT-CONNECT in Nuremberg, Germany. This major event for the medical technology sector will take place at Exhibition Centre Nuremberg. Co-organized by the Bavarian Government and co-sponsors by EIT Health HQ – this...
Meet Rheonova at the Francophone Cystic Fibrosis Days!
Rheonova will be present at the 3rd Francophone Day of Cystic Fibrosis, Lyon, April 5th-7th 2018. Every 2 years, patients and health professionals meet together during this event organized by Vaincre la Mucoviscidose and by the French Society of Cystic Fibrosis (SFM)....
Rheonova organizes demonstrations of Rheomuco!
You are working on respiratory diseases such as cystic fibrosis, COPD or asthma? Demonstrations of Rheomuco are regularly organized on our site, on the sites of our partners or on your premises. Contact us to learn more about Rheomuco's apps!
Rheonova will be present at the 22nd CPLF, Lyon, 26-28 January 2018
On January 26, 2018, come to listen to Jeremy Patarin’s presentation, CEO of Rheonova, on the rheology of bronchial secretions as a tool for monitoring cystic fibrosis and evaluating the efficacy of new treatments, as well as the evaluation of the rheological...
Rheonova will be present at Biofit, November 28-29, in Strasbourg
Rheonova will participate at the Biofit business convention that will be held in Strasbourg on 28 and 29 November 2017. We will have the opportunity to present our laboratory equipment, Rheomuco, allowing the measurement of the viscoelastic properties of...
Rheonova, laureate of the 19th i-LAB
Respiratory diseases will become the third leading cause of death in 2020 according to WHO, due to pollution and tobacco. The Rheomuco device developed by Rheonova is aimed at researchers and health professionals. It helps the evaluation of treatments and the...